China Chemical Regulatory China International Trade & Investment Government Affairs & Public Policy
ISLN:
909931467
Admitted:
Chinese National Bar
Law School:
Nanjing University in Nanjing, China, LL.B., 1993; Shanghai Academy of Social Science, LL.M., 1999; The George Washington University Law School, LL.M., 2002
Washington Eye Clinic 416 W Las Tunas Dr STE 304, San Gabriel, CA 91776 (626)5882518 (phone)
Education:
Medical School Louisiana State University School of Medicine at New Orleans Graduated: 1998
Procedures:
Lens and Cataract Procedures
Conditions:
Cataract Glaucoma Keratitis Retinal Detachments
Languages:
Chinese English
Description:
Dr. Huang graduated from the Louisiana State University School of Medicine at New Orleans in 1998. He works in San Gabriel, CA and specializes in Ophthalmology. Dr. Huang is affiliated with San Gabriel Valley Medical Center.
1280 Eugenia Ter, Lilburn, GA 30047 1280 Eugenia Ter, Lawrenceville, GA 30046
Ying Huang Managing
Homecrest, LLC Real Estate Property Rental
1169 Fairford Way, San Jose, CA 95129 4850 Kentfield Rd, Stockton, CA 95207
Ying Huang Professional Engineer
International Business Machines Corporation Custom Computer Programing Prepackaged Software Services Ret Mail-Order House · Electronic Computer Manufacturing · Electronic Shopping and Mail-Order Houses
555 Bailey Ave, San Jose, CA 95141 (408)4632000, (408)4633114
Ying Wei Huang
FUJIYAMA BROADVIEW HTS., INC
Ying Huang
CY SKY SUSHI INC
Ying Yao Huang President
S&W SISTERS, INC
1740 N Milpitas Blvd, Milpitas, CA 95035
Ying Ju Huang Manager
Georgia State University Alumni Association, Inc Library
Oct 2007 to 2000 Associate AttorneyRobert G. Mazeau Law Firm Hackensack, NJ Jun 2006 to Oct 2007 Associate AttorneyNissenbaum & Associates, LLC Union, NJ Sep 2005 to Jun 2006 Associate AttorneySuperior Court of New Jersey Paterson, NJ Sep 2004 to Aug 2005 Judicial Law Clerk, Hon. Thomas F. Brogan
Education:
Emory University School of Law Atlanta, GA 2004 Juris DoctorBrandeis University Waltham, MA 2000 Bachelor of Arts in Political Science
Us Patents
Method And Apparatus For Performing Encryption Of Data At Rest At A Port Of A Network Device
Jonathan M. Parlan - Los Altos CA, US Raymond J. Kloth - Saratoga CA, US Ying Huang - Sunnyvale CA, US Fabio R. Maino - Palo Alto CA, US Pawan Agrawal - San Jose CA, US
Methods and apparatus for performing encryption for data at rest at a port of a network device such as a switch are disclosed. Specifically, when data is received from a host during a write to a storage medium such as a disk, the data is encrypted by the port prior to transmitting the encrypted data to the storage medium. Similarly, when a host attempts to read data from the storage medium, the port of the network device receives the encrypted data from the storage medium, decrypts the data, and transmits the decrypted data to the host. In this manner, encryption and decryption of data at rest are supported by the port of the network device.
Low Tau Synchronizer Flip-Flop With Dual Loop Feedback Approach To Improve Mean Time Between Failure
- Santa Clara CA, US Ge Yang - Santa Clara CA, US Xi Zhang - Santa Clara CA, US Ying Huang - Santa Clara CA, US
Assignee:
Nvidia Corporation - Santa Clara CA
International Classification:
H03K 19/003 G06F 1/10 H03K 3/037
Abstract:
A flip-flop and a method of receiving a digital signal from an asynchronous domain. In one embodiment, the flip-flop includes: (1) a first loop coupled to a flip-flop input and having first and second stable states and (2) a second loop coupled to the first loop and having the first and second stable states, properties of cross-coupled inverters in the first and second loops creating a metastable state skewed toward the first stable state in the first loop and skewed toward the second stable state in the second loop. Certain embodiments of the flip-flop have lower time constant and thus a higher Mean Time Between Failure (MTBF).
Reference: Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial by Feng-Cai Zhu, Xu-Hua Guan, Yu-Hua Li, Jian-Ying Huang, Tao Jiang, Li-Hua Hou, Jing-Xin Li, Be
Date: Jul 20, 2020
Category: More news
Source: Google
Gilead Sciences, Inc Stock May Be in For a Rally Ahead of EASL
According to Merrill Lynch analyst Ying Huang who has also commented on the published abstracts Gileads 24-week sof/vel combo drug with or without ribavirin delivered a retreatment option for patients who failed initial treatment with the same combo med for 8-12 weeks. An 8-week triple combinat
Date: Apr 01, 2016
Category: Business
Source: Google
Cost of Gilead's hepatitis C pill, Sovaldi, spurs revolt
"It's just the sheer number of patients who have the disease. Multiply that number by that price," said Ying Huang, a senior biotechnology analyst at Barclays, whose clients include Gilead. "All of a sudden, you get a big number."
approved in 100 countries for kidney cancer and liver cancer, are split between Bayer and Onyx. The drug had sales of roughly $900 million last year. An expanded approval for thyroid cancer could result in an additional $300 million in peak global sales annually, said Ying Huang, a Barclays analyst.
Date: Jun 02, 2013
Category: Health
Source: Google
GlaxoSmithKline extends tender offer for Human Genome Sciences
"We continue to believe the most likely outcome will be a slightly higher bid from GSK, with no white knights coming to the table with a substantially higher bid," said Ying Huang and Brian Bourdot at Barclays Capital.